IP Library › Assignment 064691/0310
Patent Assignment
Reel/Frame 064691/0310

Assignment of Assignor's Interest

Recorded: 2023-08-24 Pages: 6
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
N-Arylmethyl Sulfonamide Negative Modulators of NR2A
Patent: 9,963,434 →
Application: 15/024,870 →
Publication: US 2016/0311782
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 18, 2017
From: ANDERSON, DAVID R; VOLKMANN, ROBERT A
To: LUC THERAPEUTICS
Reel/Frame 043894/0343 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 043894 Frame 0343. Assignor(S) Hereby Confirms the Assignment to Luc Therapeutics, Inc.. Mar 12, 2018
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.
To: LUC THERAPEUTICS, INC.
Reel/Frame 046812/0025 →
Change of Name Oct 18, 2018
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 047269/0745 →